Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
60
self-reported 51–200 band
Founded
1987
39 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,400 employees of the Group are committed to this shared vocation, source of inspiration every day.
As a world leader in cardiology, Servier's ambition is to become a renowned, focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 50% of its R&D budget to developing targeted and innovative therapies in oncology.
Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine.
To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria.
In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine.
Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €4.9 billion in 2022.
Servier Indonesia was established in 1987 under PT Parvico Bersaudara and legally founded as PT Servier Indonesia in 2005. We are focusing on 4 therapeutic areas: Cardiovascular, Hypertension, Metabolic and Chronic venous disease.
Further information, please visit www.servier.co.id
To report a suspected adverse event with a Servier drug, please visit www.servier.co.id
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | ID |
All codes: ID
Addresses
- IDJl.HR Rasuna Said Block X-5, Kav 2-3; Menara Kadin, 18th floor; Jakarta, DKI Jakarta 12950Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
How many people work at Servier Indonesia?
60 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does Servier Indonesia have offices?
One address on record, Indonesia only. Primary: Jl.HR Rasuna Said Block X-5, Kav 2-3, Menara Kadin, 18th floor, Jakarta, DKI Jakarta 12950.
Has Servier Indonesia raised funding?
None linked to this brand.
Which companies are listed alongside Servier Indonesia?
4 profiles list Servier Indonesia as a peer — 67th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Great Place To Work® Indonesia lists it back.